FDA Recalls Voriconazole Ophthalmic Solution for Sterility Assurance Failure
Pharmacy Innovations is recalling Voriconazole 10mg/ml ophthalmic solution nationwide because FDA inspection found insanitary facility conditions that compromised product sterility assurance.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves lack of sterility assurance in an ophthalmic product due to insanitary facility conditions identified during FDA inspection. No illnesses or injuries are reported. Because the hazard is theoretical with no reported harm, the severity rates as High.
Plain-English summary
Pharmacy Innovations, located in Erie, Pennsylvania, is recalling Voriconazole 10mg/ml ophthalmic solution distributed nationwide in the United States. This is a prescription eye-drop medication supplied in 10-milliliter dropper bottles with manufacturing code t20221025@32.
The FDA conducted an inspection of the manufacturing facility and found insanitary conditions. These conditions failed to assure sterility, which is a critical quality requirement for all ophthalmic products.
The recalled product was distributed nationwide. Patients and healthcare providers who have this product should contact Pharmacy Innovations or their pharmacy for guidance.
The recalled product
- Product
- VORICONAZOLE 10MG/ML (10ML DROPPER) OPH SOLUTION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
- Manufacturer
- Pharmacy Innovations
- Category
- Drug — Ophthalmic Solution
- Hazard
- sterility-failure
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- t20221025@32
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27